Zaditor and Alamast drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 2 people who take Zaditor and Alamast. Common interactions include blindness transient among males.

The phase IV clinical study analyzes what interactions people who take Zaditor and Alamast have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 25, 2023

2 people who take Zaditor and Alamast together, and have interactions are studied.


What is Zaditor?

Zaditor has active ingredients of ketotifen fumarate. It is used in eye allergy. Currently, eHealthMe is studying from 4,358 Zaditor users.

What is Alamast?

Alamast has active ingredients of pemirolast potassium. Currently, eHealthMe is studying from 16 Alamast users.

Number of Zaditor and Alamast reports submitted per year:

Zaditor and Alamast drug interactions.

Common Zaditor and Alamast drug interactions by gender *:

female:

n/a

male:

  1. Blindness transient
  2. Corneal perforation
  3. Depression
  4. Vision blurred

Common Zaditor and Alamast drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blindness transient
  2. Corneal perforation
  3. Depression
  4. Vision blurred

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Zaditor and Alamast?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Zaditor side effects:

Browse all side effects of Zaditor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zaditor interactions:

Browse all interactions between Zaditor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ketotifen fumarate and pemirolast potassium (the active ingredients of Zaditor and Alamast, respectively), and Zaditor and Alamast (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Zaditor and Alamast.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: